A detailed history of Signaturefd, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 3,298 shares of BIIB stock, worth $665,536. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,298
Previous 1,988 65.9%
Holding current value
$665,536
Previous $428,000 78.5%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$190.52 - $236.72 $249,581 - $310,103
1,310 Added 65.9%
3,298 $764,000
Q1 2024

May 03, 2024

SELL
$212.02 - $267.71 $38,375 - $48,455
-181 Reduced 8.34%
1,988 $428,000
Q4 2023

Jan 31, 2024

SELL
$222.59 - $267.94 $8,235 - $9,913
-37 Reduced 1.68%
2,169 $561,000
Q3 2023

Nov 03, 2023

SELL
$253.3 - $285.89 $88,401 - $99,775
-349 Reduced 13.66%
2,206 $566,000
Q2 2023

Aug 01, 2023

BUY
$275.25 - $318.06 $44,590 - $51,525
162 Added 6.77%
2,555 $727,000
Q1 2023

Apr 28, 2023

SELL
$256.56 - $292.34 $18,728 - $21,340
-73 Reduced 2.96%
2,393 $665,000
Q4 2022

Jan 27, 2023

BUY
$252.44 - $306.72 $185,038 - $224,825
733 Added 42.3%
2,466 $682,000
Q3 2022

Nov 08, 2022

SELL
$194.69 - $268.46 $16,353 - $22,550
-84 Reduced 4.62%
1,733 $463,000
Q2 2022

Aug 10, 2022

SELL
$187.54 - $223.02 $12,002 - $14,273
-64 Reduced 3.4%
1,817 $371,000
Q1 2022

May 02, 2022

SELL
$193.77 - $244.14 $58,906 - $74,218
-304 Reduced 13.91%
1,881 $396,000
Q4 2021

Jan 25, 2022

SELL
$223.92 - $287.77 $66,952 - $86,043
-299 Reduced 12.04%
2,185 $524,000
Q3 2021

Oct 28, 2021

BUY
$282.99 - $369.05 $22,356 - $29,154
79 Added 3.28%
2,484 $703,000
Q2 2021

Jul 26, 2021

BUY
$259.0 - $414.71 $66,304 - $106,165
256 Added 11.91%
2,405 $833,000
Q1 2021

Apr 30, 2021

BUY
$242.95 - $284.63 $8,989 - $10,531
37 Added 1.75%
2,149 $601,000
Q4 2020

Feb 11, 2021

SELL
$236.26 - $355.63 $346,120 - $520,997
-1,465 Reduced 40.96%
2,112 $517,000
Q3 2020

Nov 03, 2020

BUY
$264.77 - $305.71 $245,706 - $283,698
928 Added 35.03%
3,577 $1.02 Million
Q2 2020

Jul 30, 2020

SELL
$258.66 - $342.55 $25,866 - $34,255
-100 Reduced 3.64%
2,649 $709,000
Q1 2020

Apr 23, 2020

BUY
$268.85 - $341.04 $123,402 - $156,537
459 Added 20.04%
2,749 $870,000
Q4 2019

Feb 05, 2020

SELL
$220.06 - $304.07 $39,390 - $54,428
-179 Reduced 7.25%
2,290 $680,000
Q3 2019

Oct 16, 2019

BUY
$217.44 - $243.88 $154,817 - $173,642
712 Added 40.52%
2,469 $575,000
Q2 2019

Jul 31, 2019

SELL
$219.29 - $241.72 $77,847 - $85,810
-355 Reduced 16.81%
1,757 $411,000
Q1 2019

May 09, 2019

SELL
$216.71 - $338.96 $26,438 - $41,353
-122 Reduced 5.46%
2,112 $499,000
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $50,130 - $63,495
180 Added 8.76%
2,234 $672,000
Q3 2018

Nov 15, 2018

BUY
$293.51 - $383.83 $23,774 - $31,090
81 Added 4.11%
2,054 $726,000
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $122,579 - $146,089
476 Added 31.8%
1,973 $573,000
Q1 2018

May 08, 2018

BUY
$260.13 - $367.91 $22,371 - $31,640
86 Added 6.09%
1,497 $410,000
Q4 2017

Feb 13, 2018

BUY
$307.64 - $344.58 $31,379 - $35,147
102 Added 7.79%
1,411 $450,000
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $55,948 - $65,608
199 Added 17.93%
1,309 $410,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,110
1,110 $301,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $29.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.